| 000 | 01705 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518081700.0 | ||
| 264 | 0 | _c20200930 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1846-9558 | ||
| 024 | 7 |
_a10.2478/acph-2020-0003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Fengling | |
| 245 | 0 | 0 |
_aCurcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway. _h[electronic resource] |
| 260 |
_bActa pharmaceutica (Zagreb, Croatia) _cJun 2020 |
||
| 300 |
_a227-237 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdiet therapy |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Carriers _xchemistry |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipids _xchemistry |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNanostructures _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, TNF-Related Apoptosis-Inducing Ligand _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aYe, Xi | |
| 700 | 1 | _aZhai, Dandan | |
| 700 | 1 | _aDai, Wenting | |
| 700 | 1 | _aWu, Yifan | |
| 700 | 1 | _aChen, Jin | |
| 700 | 1 | _aChen, Weidong | |
| 773 | 0 |
_tActa pharmaceutica (Zagreb, Croatia) _gvol. 70 _gno. 2 _gp. 227-237 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2478/acph-2020-0003 _zAvailable from publisher's website |
| 999 |
_c30535588 _d30535588 |
||